Laserson served as a commander in the Public Health Service Commissioned Corps until 2007. All HCPs who work with us on clinical trials have contracts and are paid for their work on these clinical trials. Healthcare professionals (HCPs) help us identify potential volunteers for clinical trials, administer the investigational medicine or vaccine to patients, and monitor the results. She holds a bachelor’s degree from Harvard College and a Doctor of Science in infectious disease epidemiology from the Harvard T.H. Collaborating on clinical trials and research. Laserson has worked extensively in Mexico, Brazil, Russia, Lativia, and Vietnam. In addition to her work in India and Kenya, Dr. Laserson worked in CDC’s Division of Tuberculosis Elimination (DTBE), where she started her career as an EIS officer in DTBE’s International Research and Program Branch in 1997 and later became the branch’s deputy branch chief. As director, she managed a comprehensive research platform in HIV, malaria, TB, emerging infectious diseases, demographic surveillance, and programmatic service delivery of HIV care, treatment, and prevention programs. No matter what the cause, the Division of Global Health Protection (DGHP) and its. Many factors affect our health security, like infectious diseases, humanitarian crises, and the growing burden of noncommunicable diseases. Laserson also served as the director of the Kenya Medical Research Institute/CDC Research and Public Health Collaboration in Kisumu, Kenya from 2006 to 2013. Global health protection is about more than one country, one issue, or one pathogen. She also served as the CDC resident advisor and helped build the India Epidemic Intelligence Service Program.ĭr. The task was awarded against the Advancing the Future of Work at CDC BPA. In these roles, she oversaw CDC’s platform in India, provided technical assistance to support India’s developing role in Global Health Security, oversaw partnerships and collaborations with the government of India, and directed CDC’s scientific strategy in India. Booz Allen Hamilton beat out 2 other bidders to win a 2.5-year, 2M Centers for Disease Control and Prevention (CDC) task to provide a GID global response strategy for COVID-19.

Laserson was the CDC India Country Director and the CDC India Division of Global Health Protection program director for six years, based in Delhi. To realize these commitments, the World Health Assembly endorsed the WHO Global Action Plan for the Prevention and Control of NCDs 2013-2020 in May 2013. Laserson also led the BMGF’s COVID-19 response in India from 2020-2022.īefore her role at BMGF, Dr. Laserson served as the deputy director for Infectious Diseases and Vaccine Delivery, India Office of the Bill and Melinda Gates Foundation (BMGF) where she focused on programmatic support to the government of India and partners on TB, neglected tropical diseases, malaria, and vaccine delivery. Prior to becoming the director for GHC, Dr. Kayla Laserson, ScD, SM, FASTMH, is the Director for the Global Health Center (GHC) where she leads CDC’s global efforts to protect and improve health through science, policy, partnership, and evidence-based public health action.

Gid global health